Impaired Bone Microarchitecture in Patients with Hereditary Hemochromatosis and Skeletal Complications

被引:0
|
作者
Nico Maximilian Jandl
Tim Rolvien
Tobias Schmidt
Haider Mussawy
Peter Nielsen
Ralf Oheim
Michael Amling
Florian Barvencik
机构
[1] University Medical Center Hamburg-Eppendorf,Department of Osteology and Biomechanics
[2] University Medical Center Hamburg-Eppendorf,Department of Orthopedics
[3] University Medical Center Hamburg-Eppendorf,Department of Biochemistry and Molecular Cell Biology
来源
Calcified Tissue International | 2020年 / 106卷
关键词
HFE gene; Osteonecrosis; Osteoporosis; Cortical bone loss; Iron; HR-pQCT;
D O I
暂无
中图分类号
学科分类号
摘要
Hereditary hemochromatosis (HHC) is characterized by excessive intestinal iron absorption resulting in a pathological increase of iron levels. Parenchyma damage may be a consequence of iron deposition in affected organs (e.g., liver, pancreas, gonads) as well as bones and joints, leading to osteoporosis with increased fracture risk and arthropathy. Up to date, it is not known whether HHC can also be considered as a risk factor for osteonecrosis. Likewise, the underlying skeletal changes are unknown regarding, e.g., microstructural properties of bone. We aimed to study the spectrum of skeletal complications in HHC and the possible underlying microarchitectural changes. Therefore, we retrospectively analyzed all patients with HHC (n = 10) presenting in our outpatient clinic for bone diseases. In addition to dual-energy X-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT) was performed and bone turnover markers, 25-OH-D3, ferritin and transferrin saturation were measured. Cortical volumetric bone mineral density (Ct.BMD) and cortical thickness (Ct.Th) were reduced, whereas trabecular microstructure (Tb.Th) and volumetric bone mineral density (Tb.BMD) were preserved compared to age- and gender-adjusted reference values from the literature. Interestingly, the occurrence of bone complications was age dependent; while younger patients presented with osteonecroses or transient bone marrow edema, patients older than 65 years presented with fractures. Our study provides first insights into altered bone microarchitecture in HHC and sheds new light on the occurrence of osteonecrosis. If available, HR-pQCT is a useful complement to fracture risk assessment and to determine microstructural deterioration and volumetric bone mineralization deficits.
引用
收藏
页码:465 / 475
页数:10
相关论文
共 50 条
  • [21] Mutations of the HFE gene among Turkish hereditary hemochromatosis patients
    Halis Simsek
    Yasemin H. Balaban
    Engin Yilmaz
    Hale Sumer
    Yahya Buyukasik
    Cem Cengiz
    Osman Ozcebe
    Gulsen Hascelik
    Gonca Tatar
    Annals of Hematology, 2005, 84 : 646 - 649
  • [22] Mutations of the HFE gene among Turkish hereditary hemochromatosis patients
    Simsek, H
    Balaban, YH
    Yilmaz, E
    Sumer, H
    Buyukasik, Y
    Cengiz, C
    Ozcebe, O
    Hascelik, G
    Tatar, G
    ANNALS OF HEMATOLOGY, 2005, 84 (10) : 646 - 649
  • [23] Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss
    Baschant, Ulrike
    Altamura, Sandro
    Steele-Perkins, Peter
    Muckenthaler, Martina U.
    Spasic, Maja Vujic
    Hofbauer, Lorenz C.
    Steinbicker, Andrea U.
    Rauner, Martina
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2022, 33 (09) : 652 - 663
  • [24] ANALYSIS OF NATURAL KILLER CELL FUNCTIONS IN PATIENTS WITH HEREDITARY HEMOCHROMATOSIS
    Boennemann, Vivian
    Claus, Maren
    Butzeck, Barbara
    Collette, Daniela
    Broede, Peter
    Golka, Klaus
    Watzl, Carsten
    EXCLI JOURNAL, 2020, 19 : 430 - 441
  • [25] Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China
    Wu, Liyan
    Zhang, Wei
    Li, Yanmeng
    Zhou, Donghu
    Zhang, Bei
    Xu, Anjian
    Wu, Zhen
    Wu, Lina
    Li, Shuxiang
    Wang, Xiaoming
    Zhao, Xinyan
    Wang, Qianyi
    Li, Min
    Wang, Yu
    You, Hong
    Huang, Jian
    Ou, Xiaojuan
    Jia, Jidong
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [26] Coenzyme Q10 deficiency in patients with hereditary hemochromatosis
    Martinefski, Manuela R.
    Yamasato, Maria F.
    Di Carlo, Maria B.
    Daruich, Jorge R.
    Tripodi, Valeria P.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (06)
  • [27] PROTON PUMP INHIBITOR USE IS ASSOCIATED WITH IMPAIRED BONE MINERAL DENSITY BUT NOT BONE MICROARCHITECTURE IN PATIENTS WITH INFLAMMATORY RHEUMATIC AND MUSCULOSKELETAL DISEASES TAKING GLUCOCORTICOIDS
    Palmowski, A.
    Schmajuk, G.
    Yazdany, J.
    Katz, P.
    Li, J.
    Stovall, R.
    Kersey, E.
    Nielsen, S. M.
    Christensen, R.
    Bliddal, H.
    Boyadzhieva, Z.
    Schneider, U.
    Alexander, T.
    Muche, B.
    Hermann, S.
    Wiebe, E.
    Buttgereit, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 162 - 162
  • [28] Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients
    M. L. Maia
    C. S. Pereira
    G. Melo
    I. Pinheiro
    M. A. Exley
    G. Porto
    M. F. Macedo
    Journal of Clinical Immunology, 2015, 35 : 68 - 74
  • [29] Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients
    Maia, M. L.
    Pereira, C. S.
    Melo, G.
    Pinheiro, I.
    Exley, M. A.
    Porto, G.
    Macedo, M. F.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (01) : 68 - 74
  • [30] Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis
    van Aerts, Rene M. M.
    van Deursen, Cees Th. B. M.
    Koek, Ger H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (01) : 147 - 152